These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36224238)

  • 21. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
    Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z; He C; Yang F; Qin L; Lu X; Wu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Huang K; Tang Y; He L; Dai Y
    Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA HOTTIP promotes prostate cancer cells proliferation and migration by sponging
    Yang B; Gao G; Wang Z; Sun D; Wei X; Ma Y; Ding Y
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29884766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-539 inhibits prostate cancer progression by directly targeting SPAG5.
    Zhang H; Li S; Yang X; Qiao B; Zhang Z; Xu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():60. PubMed ID: 27037000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1.
    Meng Y; Hu X; Li S; Zeng X; Qiu L; Wei M; Wang Z; Han J
    BMC Cancer; 2020 Oct; 20(1):1028. PubMed ID: 33109107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
    Kong Q; Chen XS; Tian T; Xia XY; Xu P
    Oncol Rep; 2017 Feb; 37(2):803-812. PubMed ID: 27959429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.
    Zhang X; Fang J; Chen S; Wang W; Meng S; Liu B
    Cancer Med; 2019 Sep; 8(12):5716-5734. PubMed ID: 31389670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.
    Noonan EJ; Place RF; Basak S; Pookot D; Li LC
    Oncotarget; 2010 Sep; 1(5):349-58. PubMed ID: 20948989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
    Meng FJ; Meng FM; Wu HX; Cao XF
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
    Li SM; Wu HL; Yu X; Tang K; Wang SG; Ye ZQ; Hu J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):219. PubMed ID: 30185212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
    Yang ZG; Ma XD; He ZH; Guo YX
    Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
    Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
    Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.